Jason Hussey, PA
Physician Assistant · Puyallup, WANPI 1245409911
Payments from drug & device makers
What this record shows
26 manufacturers reported payments, led by Boston Scientific at 27.6% of the total. Reporting peaked in 2022 at $2,405 and has fallen 78.4% since, to $519 in 2025. Among physician assistant clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 115 payments — averaging $53.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Relievant Medsystems, Inc.$2K
- Nevro Corp.$711
- Nalu Medical, Inc.$571
- Medtronic$340
- Collegium Pharmaceutical, Inc.$324
- plus $895 from 20 others
What the payments were for
- Travel & lodging$2,69944%
- Food & beverage$3,48556%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 17 | $1,704 |
| Relievant Medsystems, Inc. | 7 | $1,639 |
| Nevro Corp. | 14 | $711 |
| Nalu Medical, Inc. | 4 | $571 |
| Medtronic | 8 | $340 |
| Collegium Pharmaceutical, Inc. | 25 | $324 |
| Saluda Medical Americas, Inc. | 4 | $151 |
| AbbVie | 7 | $141 |
| Globus Medical | 4 | $84 |
| Vertex | 3 | $66 |
| Lilly USA, LLC | 4 | $65 |
| Impel Pharmaceuticals Inc. | 2 | $38 |
| Painteq LLC | 1 | $36 |
| Biodelivery Sciences International, Inc. | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Merz Pharmaceuticals, LLC | 1 | $29 |
| Si-bone, Inc. | 1 | $28 |
| Axonics, Inc. | 1 | $28 |
| SPR Therapeutics, Inc | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Averitas Pharma Inc. | 1 | $20 |
| Pfizer | 1 | $18 |
| Amgen | 1 | $13 |
| Orexo US, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$6,133
- SPECTRA WAVEWRITER$1,035
- Nalu Neurostimulation System$497
- Omnia$257
- INTELLIS ADAPTIVESTIM$170
- GENERAL PAIN MANAGEMENT$135
- Evoke$110
- Senza$101
How this compares
$6,184 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 88 | $64,527 |
| OxycontinOxycodone Hcl | 76 | $43,985 |
| Nurtec OdtRimegepant Sulfate | 13 | $23,526 |
| Buprenorphine | 85 | $23,349 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 554 | $20,749 |
| Oxycodone Hcl | 873 | $17,494 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 461 | $17,327 |
| Fentanyl | 101 | $11,514 |
| Morphine Sulfate ErMorphine Sulfate | 340 | $9,143 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 48 | $8,696 |
| SymproicNaldemedine Tosylate | 12 | $5,608 |
| Lidocaine | 70 | $4,964 |
| Gabapentin | 273 | $4,654 |
| Buprenorphine Hcl | 17 | $2,340 |
| Methocarbamol | 117 | $2,137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $324 | $64,52788 claims |
| PfizerNurtec Odt | $18 | $23,52613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,741 physician assistant providers in Washington.
Other physician assistant in Puyallup
- Kari WalenPuyallup$7K
- Jill KandoraShoreline$437K
- Jeannette HartRichland$263K
- Lance KeckTacoma$162K
- Erinn KingSeattle$129K
- Christy VathSeattle$75K
- Scott TaylorMercer Island$71K
- Gina FragioneGraham$69K
- Regan BrownSpokane$56K
- Justin ChapinSeattle$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.